scholarly journals I’ll Show You Mine, If You Show Me Yours

2001 ◽  
Vol 1 ◽  
pp. 33-33

The human genome dominated science news last week. Both Science and Nature lead this week with articles about the simultaneous publication of the human genome sequence by the private company Celera Genomics and the publicly funded Human Genome Project (HGP).

Author(s):  
John Archibald

The initial phase of human genome sequencing is often referred to as ‘the’ Human Genome Project. But there were two different projects, one publicly funded, the other supported by a private company, Craig Venter’s Celera Genomics. ‘The human genome in biology and medicine’ explains that both projects used DNA samples from more than one person. It was not until 2007 that the first genome of a single individual was published. The structure of the nuclear DNA and mitochondrial genome is also described. Genomics research is having a profound impact on our understanding of the genetic, biochemical, and cell biological underpinnings of cancer, and how it can be detected and treated.


Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. SCI-16-SCI-16
Author(s):  
Eric D. Green

Abstract Abstract SCI-16 The Human Genome Project's completion of the human genome sequence in 2003 was a landmark scientific achievement of historic significance. It also signified a critical transition for the field of genomics, as the new foundation of genomic knowledge started to be used in powerful ways by researchers and clinicians to tackle increasingly complex problems in biomedicine. To exploit the opportunities provided by the human genome sequence and to ensure the productive growth of genomics as one of the most vital biomedical disciplines of the 21st century, the National Human Genome Research Institute (NHGRI) is pursuing a broad vision for genomics research beyond the Human Genome Project. This vision includes facilitating and supporting the highest-priority research areas that interconnect genomics to biology, to health, and to society.Current efforts in genomics research are focused on using genomic data, technologies, and insights to acquire a deeper understanding of biology and to uncover the genetic basis of human disease. Some of the most profound advances are being catalyzed by revolutionary new DNA sequencing technologies; these methods are already producing prodigious amounts of DNA sequence data, including from large numbers of individual patients. Such a capability, coupled with better associations between genetic diseases and specific regions of the human genome, are accelerating our understanding of the genetic basis for complex genetic disorders and for drug response. Together, these developments will usher in the era of genomic medicine. Disclosures: No relevant conflicts of interest to declare.


Biomolecules ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. 90
Author(s):  
Ryuji Hamamoto

The Human Genome Project, completed in 2003 by an international consortium, is considered one of the most important achievements for mankind in the 21st century [...]


Sign in / Sign up

Export Citation Format

Share Document